0
0
Home » Medical Devices

COVID-19 Impact on Koninklijke Philips NV’s Revenue and Operations (Medical Devices)

Koninklijke Philips NV (Philips), is a diversified technology company that develops and manufactures medical systems, consumer electronics and lighting products, headquartered in Netherlands with its operational presence in South Korea, the US, Japan, China and other countries. Philips's product range includes the patient care and clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions sleep, respiratory care, and respiratory drug delivery products, diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The report, COVID-19 Impact on Koninklijke Philips NV's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Koninklijke Philips NV is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Koninklijke Philips NV –

– It provides insights on Koninklijke Philips NV's exposure to the regions and businesses impacted by the COVID-19 outbreak.

– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Key Highlights

The overall sales in different geographies decreased by 6% in the previous quarter. As China returned to growth, it has shown a positive growth with only a mid-single digit decline in comparison to India and other North American countries which showed a double digit decline.

Reasons to Buy

An overview of how Koninklijke Philips NV will be affected by the COVID-19 pandemic.

Key Players

Koninklijke Philips NV (Philips), is a diversified technology company that develops and manufactures medical systems, consumer electronics and lighting products, headquartered in Netherlands with its operational presence in South Korea, the US, Japan, China and other countries. Philips's product range includes the patient care and clinical informatics, imaging systems, healthcare transformation services and home healthcare solutions sleep, respiratory care, and respiratory drug delivery products, diagnostic x-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The report, COVID-19 Impact on Koninklijke Philips NV's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Koninklijke Philips NV is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Table of Contents

Table of Contents

COVID-19 impact analysis on Koninklijke Philips NV (Philips) – Key Findings

Koninklijke Philips NV (Philips) Key Facts

Geographic spread analysis – COVID-19 vs Koninklijke Philips NV (Philips) sales

The impact of COVID-19 on regional GDP per capita levels

Koninklijke Philips NV (Philips) exposure: revenues by region and market vs regional impact levels

Koninklijke Philips NV (Philips) : revenue impact by region and market for 2020

Operational reactions from Koninklijke Philips NV (Philips)? Indications from recruitment trends

Operational reactions from Koninklijke Philips NV (Philips) Indications from US pricing trends

Contact us

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports